A Study on the Relationship Between Gastric Xanthoma and Gastric Cancer and Precancerous Lesions
1 other identifier
observational
1,260
1 country
1
Brief Summary
To explore the effects of gastric xanthoma on gastric cancer and its precancerous lesions, so as to better prevent the occurrence and development of gastric cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2023
CompletedFirst Submitted
Initial submission to the registry
February 21, 2024
CompletedFirst Posted
Study publicly available on registry
February 28, 2024
CompletedFebruary 28, 2024
February 1, 2024
9 months
February 21, 2024
February 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
corelation between the gastric xanthoma and gastric mucosa diseases
we evaluate the corelation between the gastric xanthoma and gastric mucosa diseases according to the histopathological results and the scales the patients finished
up to 6 months
Study Arms (3)
chronic gastritis
patients with chronic non-atrophic gastritis and chronic atrophic gastritis according to histopathological results
precancerous lesion
patients with gastric intestinal metaplasia and intraepithelial neoplasia according to histopathological results
gastric cancer
patients with gastric cancer according to histopathological results
Eligibility Criteria
Patients undergoing upper gastrointestinal endoscopy at Xijing Hospital
You may qualify if:
- Age range from 18 to 75 years old, regardless of gender;
- Endoscopic/pathological diagnosis: chronic non atrophic gastritis/chronic atrophic gastritis/intestinal metaplasia/dysplasia Hyperplasia/gastric cancer
- Voluntarily sign an informed consent form.
You may not qualify if:
- Previously underwent upper gastrointestinal surgery
- Previous diagnosis of malignant tumors
- Individuals who are unable to cooperate with the questionnaire survey due to mental disorders or other reasons
- Those who cannot be observed by endoscopy due to acute upper gastrointestinal bleeding or other reasons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Xijing Hosipital of Digestive Disease
Xi'an, Shaanxi, 710032, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yongquan Shi, PhD
Xijing Hosipital of Digestive Disease
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Clinical Professor
Study Record Dates
First Submitted
February 21, 2024
First Posted
February 28, 2024
Study Start
September 1, 2022
Primary Completion
June 1, 2023
Study Completion
September 29, 2023
Last Updated
February 28, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share